Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish

Abstract Attention deficit-hyperactivity disorder (ADHD) is a prevalent neuropsychiatric disorder found in children. It is characterized by inattention, hyperactivity, and impulsivity. Methylphenidate (MPH) and atomoxetine (ATX) are commonly prescribed for the treatment of ADHD. In the present study...

Full description

Bibliographic Details
Main Authors: Shiho Suzuki, Ryo Kimura, Shingo Maegawa, Masatoshi Nakata, Masatoshi Hagiwara
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Molecular Brain
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13041-020-00614-4
_version_ 1818923166177689600
author Shiho Suzuki
Ryo Kimura
Shingo Maegawa
Masatoshi Nakata
Masatoshi Hagiwara
author_facet Shiho Suzuki
Ryo Kimura
Shingo Maegawa
Masatoshi Nakata
Masatoshi Hagiwara
author_sort Shiho Suzuki
collection DOAJ
description Abstract Attention deficit-hyperactivity disorder (ADHD) is a prevalent neuropsychiatric disorder found in children. It is characterized by inattention, hyperactivity, and impulsivity. Methylphenidate (MPH) and atomoxetine (ATX) are commonly prescribed for the treatment of ADHD. In the present study, we examined the behavioral and brain transcriptome changes in MPH-treated and ATX-treated zebrafish. In behavioral analysis, zebrafish showed opposite response to each treatment. MPH-treated fish showed higher anxiety-like behavior while ATX-treated fish showed lower anxiety-like behavior. Further, we performed RNA sequencing analysis of zebrafish brain to elucidate the underlying biological pathways associated with MPH and ATX treatment. Interestingly, we found that shared differentially expressed genes in MPH-treated and ATX-treated fish were instrumental in cholesterol biosynthesis pathway and were regulated in opposite manner. Our findings highlight the contrast between MTH and ATX, and may suggest the alterations in clinical practice for these medications and drug development for ADHD.
first_indexed 2024-12-20T02:05:07Z
format Article
id doaj.art-e86768a3e75849e28e1184bbd2c90f94
institution Directory Open Access Journal
issn 1756-6606
language English
last_indexed 2024-12-20T02:05:07Z
publishDate 2020-05-01
publisher BMC
record_format Article
series Molecular Brain
spelling doaj.art-e86768a3e75849e28e1184bbd2c90f942022-12-21T19:57:13ZengBMCMolecular Brain1756-66062020-05-011311410.1186/s13041-020-00614-4Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafishShiho Suzuki0Ryo Kimura1Shingo Maegawa2Masatoshi Nakata3Masatoshi Hagiwara4Department of Anatomy and Developmental Biology, Graduate School of Medicine, Kyoto UniversityDepartment of Anatomy and Developmental Biology, Graduate School of Medicine, Kyoto UniversityDepartment of Intelligence Science and Technology, Graduate School of Informatics, Kyoto UniversityDepartment of Anatomy and Developmental Biology, Graduate School of Medicine, Kyoto UniversityDepartment of Anatomy and Developmental Biology, Graduate School of Medicine, Kyoto UniversityAbstract Attention deficit-hyperactivity disorder (ADHD) is a prevalent neuropsychiatric disorder found in children. It is characterized by inattention, hyperactivity, and impulsivity. Methylphenidate (MPH) and atomoxetine (ATX) are commonly prescribed for the treatment of ADHD. In the present study, we examined the behavioral and brain transcriptome changes in MPH-treated and ATX-treated zebrafish. In behavioral analysis, zebrafish showed opposite response to each treatment. MPH-treated fish showed higher anxiety-like behavior while ATX-treated fish showed lower anxiety-like behavior. Further, we performed RNA sequencing analysis of zebrafish brain to elucidate the underlying biological pathways associated with MPH and ATX treatment. Interestingly, we found that shared differentially expressed genes in MPH-treated and ATX-treated fish were instrumental in cholesterol biosynthesis pathway and were regulated in opposite manner. Our findings highlight the contrast between MTH and ATX, and may suggest the alterations in clinical practice for these medications and drug development for ADHD.http://link.springer.com/article/10.1186/s13041-020-00614-4Attention deficit-hyperactivity disorder (ADHD)BehaviorLipid metabolismMethylphenidateAtomoxetineZebrafish
spellingShingle Shiho Suzuki
Ryo Kimura
Shingo Maegawa
Masatoshi Nakata
Masatoshi Hagiwara
Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
Molecular Brain
Attention deficit-hyperactivity disorder (ADHD)
Behavior
Lipid metabolism
Methylphenidate
Atomoxetine
Zebrafish
title Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
title_full Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
title_fullStr Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
title_full_unstemmed Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
title_short Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
title_sort different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
topic Attention deficit-hyperactivity disorder (ADHD)
Behavior
Lipid metabolism
Methylphenidate
Atomoxetine
Zebrafish
url http://link.springer.com/article/10.1186/s13041-020-00614-4
work_keys_str_mv AT shihosuzuki differenteffectsofmethylphenidateandatomoxetineonthebehaviorandbraintranscriptomeofzebrafish
AT ryokimura differenteffectsofmethylphenidateandatomoxetineonthebehaviorandbraintranscriptomeofzebrafish
AT shingomaegawa differenteffectsofmethylphenidateandatomoxetineonthebehaviorandbraintranscriptomeofzebrafish
AT masatoshinakata differenteffectsofmethylphenidateandatomoxetineonthebehaviorandbraintranscriptomeofzebrafish
AT masatoshihagiwara differenteffectsofmethylphenidateandatomoxetineonthebehaviorandbraintranscriptomeofzebrafish